Karyopharm Therapeut (KPTI)

$1.12 0.03 (2.75%)
12:13 EDT KPTI Stock Quote Delayed 30 Minutes

KPTI Stock Earnings: Karyopharm Therapeutics Beats EPS, Misses Revenue for Q1 2024

By InvestorPlace Earnings
KPTI stock results show that Karyopharm Therapeutics beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.

7 Biotech Penny Stocks on the Verge of Clinical Trial Victory

Why Is Karyopharm Therapeutics (KPTI) Stock Up 21% Today?

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

More Articles
Select Price, Percent change, or Dollar change as the y-axis.
Select Area, Line, OHLC or Candlestick as the chart type.
Previous Close -
Market Cap 127.69M
PE Ratio -1.23
EPS -0.91
Volume (Avg. Vol.) 670,128
Day's Range $1.10 - $1.17
52-Week Range $0.62 - $2.14
Dividend & Yield N/A (N/A)